Comparative effectiveness of calabadion and sugammadex to reverse non-depolarizing neuromuscular-blocking agents

Anesthesiology

Volumn 123, Issue 6, 2015, Pages 1337-1349

  Haerter, Friederike ^a   Simons, Jeroen Cedric Peter ^a   Foerster, Urs ^b   Duarte, Ingrid Moreno ^a   Diaz Gil, Daniel ^a   Ganapati, Shweta ^c   Eikermann Haerter, Katharina ^a   Ayata, Cenk ^a   Zhang, Ben ^c   Blobner, Manfred ^b   Isaacs, Lyle ^c   Eikermann, Matthias ^a,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c Bldg 142   (United States)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALABADION; CISATRACURIUM; NEOSTIGMINE; NEUROMUSCULAR BLOCKING AGENT; ROCURONIUM; SUGAMMADEX; UNCLASSIFIED DRUG; VECURONIUM; ANDROSTANE DERIVATIVE; ATRACURIUM BESILATE; CALABADION 1; FUSED HETEROCYCLIC RINGS; GAMMA CYCLODEXTRIN DERIVATIVE; SULFONIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; COMPARATIVE EFFECTIVENESS; COMPETITIVE BINDING ASSAY; DOSE RESPONSE; DRUG ELIMINATION; DRUG POTENCY; EX VIVO STUDY; HEART RATE; HEMIDIAPHRAGM; MALE; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR TRANSMISSION; NONHUMAN; PHRENIC NERVE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUADRICEPS FEMORIS MUSCLE; RAT; RELATIVE BINDING AFFINITY; URINALYSIS; URINARY EXCRETION; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; COMPARATIVE STUDY;

ANDROSTANOLS; ANIMALS; ATRACURIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; GAMMA-CYCLODEXTRINS; HETEROCYCLIC COMPOUNDS, 4 OR MORE RINGS; MALE; NEOSTIGMINE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; RATS; SULFONIC ACIDS; VECURONIUM BROMIDE;

EID: 84947493249     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0000000000000868     Document Type: Article

References (33)

1. Eikermann M, Blobner M, Groeben H, Rex C, Grote T, Neuhäuser M, Beiderlinden M, Peters J, Postoperative upper airway obstruction after recovery of the train of four ratio of the adductor pollicis muscle from neuromuscular blockade. Anesth Analg 2006 102 937 42
2. Heier T, Caldwell JE, Feiner JR, Liu L, Ward T, Wright PM, Relationship between normalized adductor pollicis train-of-four ratio and manifestations of residual neuromuscular block: A study using acceleromyography during near steady-state concentrations of mivacurium. A nesthesiology 2010 113 825 32
3. Arbous MS, Meursing AE, van Kleef JW, De Lange JJ, Spoormans HH, Touw P, Werner FM, Grobbee DE, Impact of anesthesia management characteristics on severe morbidity and mortality. A nesthesiology 2005 102 257 68
4. Fuchs-Buder T, Meistelman C, Alla F, Grandjean A, Wuthrich Y, Donati F, Antagonism of low degrees of atracurium-induced neuromuscular blockade: Dose-effect relationship for neostigmine. A nesthesiology 2010 112 34 40
5. Caldwell JE, Robertson EN, Baird WL, Antagonism of profound neuromuscular blockade induced by vecuronium or atracurium. Comparison of neostigmine with edrophonium. Br J Anaesth 1986 58 1285 9
6. Srivastava A, Hunter JM, Reversal of neuromuscular block. Br J Anaesth 2009 103 115 29
7. Fuchs-Buder T, Claudius C, Skovgaard LT, Eriksson LI, Mirakhur RK, Viby-Mogensen J, 8th International Neuromuscular Meeting Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: The Stockholm revision. Acta Anaesthesiol Scand 2007 51 789 808
8. Payne JP, Hughes R, Al Azawi S, Neuromuscular blockade by neostigmine in anaesthetized man. Br J Anaesth 1980 52 69 76
9. Caldwell JE, Miller RD, Clinical implications of sugammadex. Anaesthesia 2009 64 (suppl 1) 66 72
10. Takazawa T, Tomita Y, Yoshida N, Tomioka A, Horiuchi T, Nagata C, Orihara M, Yamada MH, Saito S, Three suspected cases of sugammadex-induced anaphylactic shock. BMC Anesthesiol 2014 14 92
11. Menéndez-Ozcoidi L, Ortiz-Gómez JR, Olaguibel-Ribero JM, Salvador-Bravo MJ, Allergy to low dose sugammadex. Anaesthesia 2011 66 217 9
12. Rahe-Meyer N, Fennema H, Schulman S, Klimscha W, Przemeck M, Blobner M, Wulf H, Speek M, McCrary Sisk C, Williams-Herman D, Woo T, Szegedi A, Effect of reversal of neuromuscular blockade with sugammadex versus usual care on bleeding risk in a randomized study of surgical patients. A nesthesiology 2014 121 969 77
13. Sugammadex FDA Approval Status 2015 Drugs.com. Available at: http://www.drugs.com/history/sugammadex.html. Accessed July 24, 2015
14. Lagona J, Mukhopadhyay P, Chakrabarti S, Isaacs L, The cucurbit[n]uril family. Angew Chem Int Ed Engl 2005 44 4844 70
15. Masson E, Ling X, Joseph R, Kyeremeh-Mensah L, Lu X, Cucurbituril chemistry: A tale of supramolecular success. RSC Adv 2012 2 1213
16. Hoffmann U, Grosse-Sundrup M, Eikermann-Haerter K, Zaremba S, Ayata C, Zhang B, Ma D, Isaacs L, Eikermann M, Calabadion: A new agent to reverse the effects of benzylisoquinoline and steroidal neuromuscular-blocking agents. A nesthesiology 2013 119 317 25
17. Ma D, Zhang B, Hoffmann U, Sundrup MG, Eikermann M, Isaacs L, Acyclic cucurbit[n]uril-type molecular containers bind neuromuscular blocking agents in vitro and reverse neuromuscular block in vivo. Angew Chem Int Ed Engl 2012 51 11358 62
18. Da Ma, Hettiarachchi G, Nguyen D, Ben Zhang, Wittenberg JB, Zavalij PY, Briken V, Isaacs L, Acyclic cucurbit[n]uril molecular containersenhance the solubility and bioactivity of poorlysoluble pharmaceuticals. Nat Chem 2014 4 503 10
19. Eikermann M, Fassbender P, Malhotra A, Takahashi M, Kubo S, Jordan AS, Gautam S, White DP, Chamberlin NL, Unwarranted administration of acetylcholinesterase inhibitors can impair genioglossus and diaphragm muscle function. A nesthesiology 2007 107 621 9
20. Eikermann M, Zaremba S, Malhotra A, Jordan AS, Rosow C, Chamberlin NL, Neostigmine but not sugammadex impairs upper airway dilator muscle activity and breathing. Br J Anaesth 2008 101 344 9
21. Reeve R, Turner JR, Pharmacodynamic models: Parameterizing the hill equation, Michaelis-Menten, the logistic curve, and relationships among these models. J Biopharm Stat 2013 23 648 61
22. De Kam PJ, Grobara P, Prohn M, Höppener F, Kluft C, Burggraaf J, Langdon RB, Peeters P, Effects of sugammadex on activated partial thromboplastin time and prothrombin time in healthy subjects. Int J Clin Pharmacol Ther 2014 52 227 36
23. Paton WD, Waud DR, The margin of safety of neuromuscular transmission. J Physiol 1967 191 59 90
24. Gamal-Eldin MA, Macartney DH, Cucurbit[7]uril host-Guest complexations of steroidal neuromuscular blocking agents in aqueous solution. Can J Chem 2014 92 243 9
25. Bom A, Bradley M, Cameron K, Clark JK, Van Egmond J, Feilden H, MacLean EJ, Muir AW, Palin R, Rees DC, Zhang MQ, A novel concept of reversing neuromuscular block: Chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angew Chem Int Ed Engl 2002 41 266 70
26. Hemmerling TM, Zaouter C, Geldner G, Nauheimer D, Sugammadex-A short review and clinical recommendations for the cardiac anesthesiologist. Ann Card Anaesth 2010 13 206 16
27. Kopman AF, Eikermann M, Antagonism of non-depolarising neuromuscular block: Current practice. Anaesthesia 2009 64 (suppl 1) 22 30
28. Zaimis EJ, Motor end-plate differences as a determining factor in the mode of action of neuromuscular blocking substances. J Physiol 1953 122 238 51
29. Hobbiger F, Peck AW, Hydrolysis of suxamethonium by different types of plasma. Br J Pharmacol 1969 37 258 71
30. Zhang B, Zavalij PY, Isaacs L, Acyclic CB[n]-type molecular containers: Effect of solubilizing group on their function as solubilizing excipients. Org Biomol Chem 2014 12 2413 22
31. Cammu G, De Kam PJ, De Graeve K, van den Heuvel M, Suy K, Morias K, Foubert L, Grobara P, Peeters P, Repeat dosing of rocuronium 1.2 mg kg-1 after reversal of neuromuscular block by sugammadex 4.0 mg kg-1 in anaesthetized healthy volunteers: A modelling-based pilot study. Br J Anaesth 2010 105 487 92
32. European Medicines Agency, Committee for Medical Products in Human Use (CHMP) Report Number WC500052310 2014:1-32. Available at: www.ema.europa.eu%2fdocs%2fet-EE%2fdocument-library%2fEPAR---Product-Information%2fhuman%2f000885%2fWC500052310.pdf. Accessed July 24, 2015
33. Grabitz SD, Ganapati S, Cotten JF, Isaacs L, Eikermann M, Calabadion binds cocaine in vitro and reverses cocaine's behavioral effects dose-dependently in vivo (abstract A1193). American Society of Anesthesiologists Annual Meeting 2015, Orlando, Florida